Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2026-01-02 @ 7:57 AM
Study NCT ID:
NCT07052695
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2025-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mosunetuzumab for CLL MRD Clearance
Sponsor:
Inhye Ahn
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-24
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-28
First Submit QC Date:
None
Study First Post Date:
2025-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED